Adult ADHD Patient Recruitment Campaign Results
By: Map & Story
ATLANTA – May 18, 2020 – PRLog — Map & Story, Inc, completes a local digital ad campaign for Adult ADHD Research Study in the Atlanta, Georgia area.
As a white-label services provider for a large marketing agency, Map & Story provided 469 targeted referrals in the 3 week period with an excellent 25% conversion per click rate.
The 3 week ad campaign targeted males and females, ages 21-65, with a confirmed interest in Adult ADHD. If prescreen questions were answered in a manner consistent with the study guidelines, the referral was forwarded to the study site in real time. Prescreened patients were contacted directly by study staff and randomized at an above average rate.
Map & Story supplied the trial site with content for IRB approval consistent with social platform and search engine guidelines. Once IRB approval was confirmed, ads delivered to potential patients within 24 hours.
Additional services provided to the investigator included; condition/study and market specific landing page, email notifications, referral tracking, adverse reaction/comment monitoring, and ROI reporting.
Read the Project Summary here, http://www.mapandstory.com/
Map & Story CEO David Jackson says: “We are happy to partner with agencies to assist them in better servicing trial sites. We focus our lead generation efforts on an audience more likely to reach randomization, making sure recruitment budgets are spent efficiently. Other online agencies may simply accrue clicks, we make certain our leads are valuable to the study center. We were grateful for the opportunity to help this center fill their study and invite any ad agency to partner with us on their most difficult-to-
Patient recruitment remains one of the worst bottlenecks in clinical research, as more than half of studies fail to fully enroll and a large percentage of trials fail to enroll even a single patient. This slows down the development of new treatments hurting healthcare worldwide. Similarly, inefficient recruiting puts development timeline and study data at risk, causing an average delay of nearly a year on late-stage trials, increasing costs and delaying time to market.
Our social data identifies suitable patients, meets them where they are online and optimizes the conversion of targeted demographic to lead, starting them smoothly on the path to randomization.
About Map & Story, Inc:
With over two decades of digital experience, Map & Story (http://www.mapandstory.com/